Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study

Tuberkuloz ve Toraks

Volumn 58, Issue 2, 2010, Pages 119-127

  Köksal, Iftihar ^a   Özlü, Tevfik ^a   Bayraktar, Özlem ^a   Yilmaz, Gürdal ^a   Bülbül, Yilmaz ^a   Öztuna, Funda ^a   Çaylan, Rahmet ^a   Aydin, Kemalettin ^a   Sucu, Nurgün ^a   Özcan, Dilara Inan ^b   ÖǧüŞ, Candan ^b   Tekeli, Emin ^c   Kaya, Akin ^c   Ayaz, Celal ^d   Daǧli, Canan Eren ^d   Yildiz, Orhan ^e   Oymak, Fatma Sema ^e   Kalkan, Ahmet ^f   Muz, Mehmet Hamdi ^f   Turgut, Hüseyin ^g   Fişekçi, Fatma ^g   Heper, Yasemin ^h   Uzaslan, Esra ^h   more..

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^f FIRAT UNIVERSITY   (Turkey)

^g PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^h ULUDAG UNIVERSITY   (Turkey)

Author keywords

Community acquired pneumonia; Etiology of pneumonia; Risk factors

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

ADULT; ADULT DISEASE; AGED; ANTIBODY TITER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SERODIAGNOSIS; SEROEPIDEMIOLOGY; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC); URINALYSIS;

AGE FACTORS; AGED; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; TURKEY;

EID: 77955289961     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mandell LA. Epidemiology and etiology of community-acquired pneumonia. Infect Dis Clin North Am 2004; 18: 761-76.
2. Lode HM. Managing community-acquired pneumonia: a European perspective. Respir Med 2007; 101: 1864-73.
3. Mandell LA, Wunderink RG, Anzueto A, et al; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2): S27-S72.
4. Lagerström F, Bader M, Foldevi M, et al. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden. Clin Microbiol Infect 2003; 9: 645-52. (Pubitemid 36987037)
5. Ozlu T, Bulbul Y, Ozsu S. Community-acquired pneumonia based on the Turkish national data. Tuberk Toraks 2007; 55: 191-212. (Pubitemid 47067462)
6. Sener B, Tunçkanat F, Ulusoy S, et al. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005. J Antimicrob Chemother 2007; 60: 587-93.
7. Honeybourne D. Community-acquired pneumonia in ambulatory patients: relative importance of atypical pathogens. Int J Antimicrob Agents 2001; 18: 57-61
8. Ozyilmaz E, Akan OA, Gulhan M, et al. Major bacteria of community-acquired respiratory tract infections in Turkey. Jpn J Infect Dis 2005; 58: 50-2. (Pubitemid 40425376)
9. Kaygusuz S, Koksal I, Aydin K, Caylan R. Investigation of atypical bacteria and virus antigens in respiratory tract infections by use of an immunofluorescence method. Jpn J Infect Dis 2004; 57: 33-6. (Pubitemid 38679046)
10. Ozlu T, Bulbul Y, Kaygusuz S, et al. Prevalence of M. pneumoniae, C. pneumoniae and L. pneumophilia in our cases with community-acquired pneumonia. Solunum Hastaliklari 2000; 11: 135-9.
11. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; (Suppl 2): 27-72.
12. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82. (Pubitemid 36560938)
13. Charles PG, Whitby M, Fuller AJ, et al. Australian CAP Study Collaboration. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46: 1522-4.
14. Endeman H, Schelfhout V, Voorn GP, et al. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 2008; 8: 1-6.
15. Song JH, Oh WS, Kang CI, et al. Asian Network for Surveillance of Resistant Pathogens Study Group. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008; 31: 107-14.
16. Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax 2006; 61: 75-9.
17. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296-301.
18. Almirall J, Boixeda R, Bolíbar I, et al; GEMPAC Study Group. Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study. Respir Med 2007; 101: 2168-75.
19. Angeles Marcos M, Camps M, Pumarola T, et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther 2006; 11: 351-9. (Pubitemid 43823554)
20. Miyashita N, Fukano H, Mouri K, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol 2005; 54: 395-400. (Pubitemid 40489548)
21. Díaz A, Barria P, Niederman M, et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 2007; 131: 779-87. (Pubitemid 46446870)
22. Beovic B, Bonac B, Kese D, et al. Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 2003; 22: 584-91. (Pubitemid 37363536)
23. Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-acquired pneumonia in southeast Asia the microbial differences between ambulatory and hospitalized patients. Chest 2003; 123: 1512-19. (Pubitemid 36549770)
24. Bochud PY, Moser F, Erard P, et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore). 2001; 80: 75-87.
25. Logroscino CD, Penza O, Locicero S, et al. Community-acquired pneumonia in adults: a multicentric observational AIPO study. Monaldi Arch Chest Dis 1999; 54: 11-7. (Pubitemid 29154859)
26. Moine P, Vercken JB, Chevret S, et al. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French study group for community-acquired pneumonia in the intensive care unit. Chest 1994; 105: 1487-95.
27. Lauderdale TL, Chang FY, Ben RJ, et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005; 99: 1079-86.
28. Sohn JW, Park SC, Choi YH, et al. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multicenter study. J Korean Med Sci 2006; 21: 602-7.
29. Gutiérrez F, Masiá M, Rodríguez JC, et al. Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis 2005; 24: 377-83.
30. st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 2005; 11: 788-800.
31. Howard LS, Sillis M, Pasteur MC, et al. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect 2005; 50: 107-13
32. Arnold FW, Summersgill JT, Lajoie AS, et al. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175: 1086-93
33. Gutiérrez F, Masiá M, Mirete C, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006; 53: 166-74. (Pubitemid 44227814)
34. Özlü T, Bülbül Y, Alataş F, Arseven O ve ark. Türk Toraks Derneǧi erişkinlerde toplumda gelişen pnömoni tani ve tedavi uzlaşi raporu. Turkish Thoracic Journal 2009; Ek 9.